Supreme Court: Generic-Drug Makers Can't Be Sued Under State Law For Design Defects by Lawrence Hurley and Bill Berkrot. Washington Post. June 24, 2013.
(1) About _________% of U.S. prescriptions are filled with generics.
(2) According to the majority opinion, _______________ could not run against federals laws on labeling prescription medicines whose design has been approved by the FDA.
(3) A 2011 Court ruling found that branded drugs are ____________ while makers of generics ________.
(4) The Court agreed that federal law requires generic drugs to the same_______________________.
(5) What happens under the ruling if a dangerous side effect of the medicine does not come to light until long after it was approved by the FDA and perhaps there is no branded label on the market?
No comments:
Post a Comment